Dr. Saro H. Armenian is the Barron Hilton Chair and Professor of Pediatrics and Director of the Division of Outcomes Research in the Department of Population Sciences at City of Hope. A Leukemia & Lymphoma Society Scholar, he leads NIH-funded research focused on the mechanisms, risk prediction, and prevention of cardiovascular disease in cancer survivors.

Dr. Lynda Balneaves is a Full Professor and Associate Dean, Research in the College of Nursing, University of Manitoba. Her research focuses on the use of complementary therapies by individuals with cancer. She is past president of the Society for Integrative Oncology.  

Dr. Carson is a Program Leader for the Health Outcomes and Behavior Research Program and an Associate Member in the Department of Health Outcomes and Behavior at Moffitt Cancer Center in Tampa, FL. She is a Moffitt Distinguished Scholar and the inaugural George Edgecomb Endowed Scholar. She completed her Bachelor’s degree in Biology at Florida State University. She received her Master’s degree and Ph.D. in Epidemiology from the University of Alabama at Birmingham and completed a post-doctoral fellowship at the University of Arkansas for Medical Sciences.  As an applied epidemiologist, Dr. Carson has made significant contributions to the field of obesity treatment and cancer risk reduction research through her population-based, bio-behavioral observational and intervention studies. Dr. Carson is currently the PI of 2 NIH-funded R01 studies investigating behavioral and biological aspects of energy balance, cancer prevention, and health disparities. She also serves as a co-investigator on Team SAMBAI, a Cancer Grand Challenges team examining cancer outcomes in a global context. In addition to a robust research program, Dr. Carson is dedicated to mentoring with an extensive track record of providing mentorship at levels ranging from undergraduate to junior faculty.

Dr. Susan Chang is a Professor in the Division of NeuroOncology and specializes in treating adults with brain tumors. She is a co-leader for the NeuroOncology Program for the Helen Diller Family Comprehensive Cancer Center and a Principal Investigator in the Brain Tumor Center. She has a major research focus on the development of novel therapies for patients and has served as the PI on numerous clinical trials. She is a leader on multi-programmatic grants (including NIH funded SPORE and Program Project Grants) that address the integration of physiologic and metabolic imaging with genomic biomarkers to optimize the management of patients with primary brain tumors. She is also a co-leader for a grant that addresses the interplay of genomic and immune characteristics with external factors that affect health outcomes in patients with meningioma, prostate and breast cancer. Dr. Chang is especially dedicated to improving the experience of her patients and their families, with a particular focus on increasing quality of life. She is the founder, Co-Director and Endowed Professor of the UCSF Neuro-Oncology Gordon Murray Caregiver Program, which provides resources and support to the caregivers of brain tumor patients. She is also the co-Director of the Sheri Sobrato Brain Cancer Survivorship Program focused on comprehensive survivorship care for brain tumor patients.

Verlycia Dixon transitioned from being a medical assistant of 3 years to CHW in 2017. This change was birthed out of a passion for helping people and working in the community propelling her into doing community work full time at Henry Ford Health. As a CHW she has the pleasure of helping patients move past barriers that will prevent getting needed care for physical recovery.  She does this by forming relationships with patients that extend outside of the Henry Ford Health System. She is involved in several committees that are centered around diversity, equity, inclusion and justice as it is important to her that all persons, regardless of color, gender, age, sexual orientation, be treated equally within the health system.

Dr. Heather Greenlee is a cancer epidemiologist and a naturopathic physician.  She is a Professor in the Public Health Sciences and Clinical Research Divisions at the Fred Hutchinson Cancer Center and is the Medical Director of the Integrative Medicine Program.  She is also a Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and is an Adjunct Professor in the Department of Epidemiology at the University of Washington School of Public Health. Dr. Greenlee’s research focuses on the use of lifestyle modifications and complementary and integrative therapies for cancer prevention and survivorship, especially in populations underrepresented in research.  She uses observational studies and clinical trials to study what cancer survivors can do, in addition to conventional treatment, to prevent cancer recurrence, decrease side effects of treatment, and improve prognosis.  Dr. Greenlee is an active member of SWOG within the National Cancer Institute’s National Cancer Clinical Trials Network and is Past President of the Society for Integrative Oncology.  Her work is funded by the National Cancer Institute and she is an inaugural recipient of the Washington State Cancer Research Distinguished Researcher Grant.

Nofisat Ismaila, PhD, is a Senior Clinical Guideline Specialist at the American Society of Clinical Oncology (ASCO) with over 12 years of experience in health research methodology and guideline development. In her role, she supports multidisciplinary Expert Panels in the creation of evidence-based clinical practice guidelines and the transition of high-priority topics into the Living Guideline model. Dr. Ismaila plays a pivotal role in maintaining rigorous GRADE methodology standards and structured data processes that ensure ASCO’s recommendations are transparent, implementable, and current. Her recent work focuses on how these robust methodological frameworks, including the integration of AI and automated tools into the guideline development cycle, serve as the essential foundation for AI-driven dissemination and clinical decision-support tools.

Dr. Movsas is a nationally recognized expert in the field of radiation oncology, stereotactic radiosurgery, lung cancer, prostate cancer, and quality of life issues pertaining to cancer. He has published extensively in many prestigious medical journals and regularly presents his research findings at some of the nation’s top medical meetings. Dr. Movsas has been a leader in the most prominent academic organizations, including as President of the American Society for Radiation Oncology (ASTRO) Society of Chairs of Academic Radiation Oncology Programs (SCAROP), and President of the American Radium Society (ARS). He serves as the Chair of the National Cancer Institute (NCI) Patient Centered Outcomes Committee (PCOR) of the NRG cooperative group. He is recognized as a Fellow of the American Society of Radiation Oncology (ASTRO), the American College of Radiology (ACR), and the American Radium Society (ARS). He has also served as Chair of the Education Council on the ASTRO Board of Directors.

Margaret Raber is an Assistant Professor in the Department of Health Disparities Research at the University of Texas MD Anderson Cancer Center. Dr. Raber’s research, teaching and community service activities focus on practical nutrition education and food insecurity mitigation in cancer prevention and survivorship. She earned her Diplôme de Cuisine (culinary degree) from Le Cordon Bleu London in 2007, Bachelor of Science in Nutrition/Food Studies from New York University in 2010, Master of Public Health in 2014 and Doctorate of Public Health in Community Health Practice from the University of Texas School of Public Health in 2019. Dr. Raber’s research focuses on food is medicine approaches to cancer prevention and control. Specifically, her work aims to: 1)) identify relationships linking the home food environment, food security, diet and health, 2) build and test food security and nutrition education interventions for medically underserved populations and 3) expand culinary medicine approaches in medical school and community environments. Currently, Dr. Raber is PI of a USDA-funded project promoting healthy eating through culinary medicine and positive food parenting practices among families with low-income, as well as an American Cancer Society Research Scholar Grant examining a digital culinary medicine intervention to promote diet quality among cancer patients treated in a safety net oncology setting.  

Dr. Kathryn Schmitz is Deputy Director of the UPMC Hillman Cancer Center, a Professor of Hematology Oncology at the University of Pittsburgh School of Medicine and Former President of the American College of Sports Medicine.  As an international thought leader in exercise oncology, she is the founding president of the International Society of Exercise Oncology, which will have its inaugural meeting in July 2026.  She is also the Founder and Director of ACSM’s Moving Through Cancer initiative, which arose from the Exercise Is Medicine Initiative. She is first author of the first ACSM guidelines for exercise and cancer and senior author on the second ACSM guidelines for exercise and cancer. Dr. Schmitz is fellow of ACSM, TOS, NAK, and SBM and winner of numerous awards, including the President’s Council on Sports, Fitness, and Nutrition Lifetime Impact Award. 

Jessica Scott received her PhD from the University of British Columbia, where she studied the effects of prolonged endurance exercise on cardiac function in athletes and heart transplantation recipients. She completed a postdoctoral fellowship at NASA Johnson Space Center and then spent five years as a Senior Scientist in the Exercise Physiology and Countermeasures Laboratory, optimizing exercise training for astronauts on long-duration spaceflight missions. Her current research applies digital tools to characterize cancer therapy-related side effects and to deliver exercise interventions to mitigate treatment toxicities. At NASA, she received the Human Research Program Peer Award, the Innovation Achievement Award, and the Group Achievement Award as a member of the One Year Mission Operations Team.